Discover 1,296 paid clinical trials in Gilbert, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,296
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
for
Human Papilloma Virus (HPV),
Location: Phoenix AZ, Tucson AZ, Layton UT, Pearland TX,
Location: Phoenix AZ, Houston TX, Humble TX, Columbus OH,
Sponsor: Reprise Biomedical, Inc.
Sex: All
Age: 18+
Code: NCT07632001
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
for
Cervical Squamous Cell Carcinoma,
Location: Phoenix AZ, Los Angeles CA, San Antonio TX, Houston TX,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT07169734
Phase 1, Phase 2, Recruiting
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer
for
Pancreatic Cancer
Location: Phoenix AZ, Houston TX, Charlottesville VA, Hartford CT,
Sponsor: Craig L Slingluff, Jr
Sex: All
Age: 18+
Code: NCT02305186
Phase 1, Phase 2, Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
for
SLE, SLE (Systemic Lupus)
Location: Avondale AZ, Tucson AZ, Salt Lake City UT, Plano TX,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18 - 70
Code: NCT06613360
Phase 1, Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for
Solid Tumors With HRAS Alterations,
Location: Phoenix AZ, Tucson AZ, Los Angeles CA, Oklahoma City OK,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06026410
Phase 1, Recruiting
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
for
Sickle Cell Disease
Location: Phoenix AZ, Los Angeles CA, Clovis CA, Houston TX,
Sponsor: Sanofi
Sex: All
Age: 10 - 65
Code: NCT06975865
Phase 3, Recruiting
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial